Rincon M, Flavell R A
Section of Immunobiology, Yale University, School of Medicine, New Haven, Connecticut 06510, USA.
Mol Cell Biol. 1996 Mar;16(3):1074-84. doi: 10.1128/MCB.16.3.1074.
The ability of thymocytes to express cytokine genes changes during the different stages of thymic development. Although CD4- CD8- thymocytes are able to produce a wide spectrum of cytokines in response to a T-cell receptor (TcR)-independent stimulus, as they approach the double-positive (DP) CD4+ CD8+ stage, they lose the ability to produce cytokine. After the DP stage, thymocytes become single-positive CD4+ or CD8+ thymocytes which reacquire the ability to secrete cytokines. In an attempt to understand the molecular basis of this specific regulatin, we use AP-1-luciferase and newly generated NFAT-luciferase transgenic mice to analyze the transcriptional and DNA-binding activities of these two transcription factors that are involved in the regulation of cytokine gene expression. Here, we show that both AP-1 and NFAT transcriptional activities are not inducible in the majority of DP cells but that during the differentiation of DP cells to the mature single-positive stage, thymocytes regain this inducibility. Subpopulation analysis demonstrates that this inducibility is reacquired at the DP stage before the down-modulation of one of the coreceptors. Indeed AP-1 inducibility, just like the ability to express the interleukin-2 gene, is reacquired during the differentiation of DP TcRlow CD69low heat-stable antigen (HSA)high thymocytes to DP TcRhigh CD69high HSAhigh cells, which is considered to be the consequence of the first signal that initiates positive selection. We therefore propose that the inability of DP thymocytes to induce AP-1 and NFAT activities is one of the causes for the lack of cytokine gene expression at this stage and that this inducibility is reacquired at the latest stage of DP differentiation as a consequence of positive selection. This could be a mechanism to prevent the activation of DP thymocytes before selection has taken place.
胸腺细胞表达细胞因子基因的能力在胸腺发育的不同阶段会发生变化。尽管CD4-CD8-胸腺细胞能够在不依赖T细胞受体(TcR)的刺激下产生多种细胞因子,但随着它们接近双阳性(DP)CD4+CD8+阶段,它们失去了产生细胞因子的能力。在DP阶段之后,胸腺细胞变成单阳性CD4+或CD8+胸腺细胞,重新获得分泌细胞因子的能力。为了理解这种特异性调节的分子基础,我们使用AP-1荧光素酶和新生成的NFAT荧光素酶转基因小鼠来分析这两种参与细胞因子基因表达调节的转录因子的转录和DNA结合活性。在此,我们表明,在大多数DP细胞中,AP-1和NFAT的转录活性都不可诱导,但在DP细胞分化为成熟单阳性阶段的过程中,胸腺细胞重新获得了这种可诱导性。亚群分析表明,这种可诱导性在其中一个共受体下调之前的DP阶段重新获得。事实上,AP-1的可诱导性,就像表达白细胞介素-2基因的能力一样,在DP TcRlow CD69low热稳定抗原(HSA)高的胸腺细胞分化为DP TcR高CD69高HSA高细胞的过程中重新获得,这被认为是启动阳性选择的第一个信号的结果。因此,我们提出,DP胸腺细胞无法诱导AP-1和NFAT活性是该阶段细胞因子基因表达缺乏的原因之一,并且这种可诱导性在DP分化的最晚阶段作为阳性选择的结果重新获得。这可能是一种在选择发生之前防止DP胸腺细胞激活的机制。